glp 1 anesthesia guidelines 2025 New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Risks Emerging Frontiers in GLP-1 Therapeutics:

Mitochondrial Influence: May affect oxidative-phosphorylation efficiency or substrate preference in cellular metabolism

Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency

However, systemic copper loading remains a theoretical concern requiring careful dose optimization and copper status monitoring, particularly with chronic administration protocols

More broadly, a growing body of preclinical evidence suggests that certain postbiotic preparations may attenuate weight gain, reduce adiposity, and stimulate thermogenesis, including brown adipose tissue signaling, particularly in HFD-induced rodent models (114)